11. 重症筋無力症 Myasthenia gravis Clinical trials / Disease details

臨床試験数 : 332 / 薬物数 : 234 - (DrugBank : 81) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 127

11 trials found

diseases per page:

Showing 1 to 10 of 11 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05644561 (ClinicalTrials.gov)	January 2, 2023	1/12/2022	Evaluation of Pharmacokinetics, Pharmacodynamics, Efficacy, Safety, and Immunogenicity of Ravulizuma ...	A Phase 3, Open-label, Single-arm, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynam ...	Generalized Myasthenia Gravis;gMG	Drug: Ravulizumab	Alexion Pharmaceuticals	NULL	Not yet recruiting	6 Years	18 Years	All	12	Phase 3	NULL
2	EUCTR2018-003243-39-PT (EUCTR)	15/06/2020	06/02/2020	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR ...	Alexion Pharmaceuticals Incorporated	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 3	United States;Portugal;Spain;Austria;Russian Federation;Israel;United Kingdom;Switzerland;Italy;Fran ...
3	EUCTR2018-003243-39-GB (EUCTR)	11/02/2020	08/10/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR ...	Alexion Pharmaceuticals Incorporated	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 3	Portugal;United States;Spain;Turkey;Austria;Russian Federation;Israel;Italy;United Kingdom;Switzerla ...
4	EUCTR2018-003243-39-CZ (EUCTR)	02/01/2020	13/09/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR ...	Alexion Pharmaceuticals Incorporated	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	Portugal;United States;Spain;Turkey;Austria;Russian Federation;Israel;Italy;Switzerland;United Kingd ...
5	EUCTR2018-003243-39-AT (EUCTR)	09/10/2019	26/04/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Ravulizumab Other descriptive nam ...	Alexion Pharmaceuticals Incorporated	NULL	Not Recruiting			Female: yes Male: yes	160	Phase 3	United States;Portugal;Spain;Austria;Russian Federation;Israel;United Kingdom;Switzerland;Italy;Fran ...
6	EUCTR2018-003243-39-DK (EUCTR)	20/09/2019	22/05/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR ...	Alexion Pharmaceuticals Incorporated	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 3	Portugal;United States;Czechia;Spain;Austria;Israel;United Kingdom;Italy;Switzerland;France;Czech Re ...
7	EUCTR2018-003243-39-DE (EUCTR)	30/07/2019	25/03/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR ...	Alexion Pharmaceuticals Incorporated	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 3	United States;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Republic;Ca ...
8	EUCTR2018-003243-39-NL (EUCTR)	22/07/2019	01/05/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR ...	Alexion Pharmaceuticals Incorporated	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Phase 3	United States;Portugal;Czechia;Spain;Austria;Israel;United Kingdom;Switzerland;Italy;France;Czech Re ...
9	EUCTR2018-003243-39-IT (EUCTR)	17/06/2019	22/01/2021	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Trade Name: Ultomiris Product Name: Ravulizumab Product Code: [ALXN1210]	ALEXION PHARMACEUTICALS INCORPORATED	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	158	Phase 3	Portugal;United States;Czechia;Spain;Austria;Israel;Russian Federation;United Kingdom;Switzerland;It ...
10	EUCTR2018-003243-39-ES (EUCTR)	21/05/2019	27/05/2019	Study to evaluate the safety and efficacy of ravulizumabin adult patients with generalized Myastheni ...	A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Safety an ...	Generalized Myasthenia Gravis MedDRA version: 20.0;Level: HLT;Classification code 10071942;Term: Mya ...	Product Name: Ravulizumab Product Code: ALXN1210 INN or Proposed INN: Fc- and CDR-modified humanised m ...	Alexion Pharmaceuticals Incorporated	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	160	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United States;Canada;Spain;Denmark;Austria;Israel;Netherlands;Germany;Japan;Italy;Switzerland;Korea, ...

First Previous1 2Next Last